PD-2 EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma

التفاصيل البيبلوغرافية
العنوان: PD-2 EMERGE: A multi-centre, non-randomised, single-arm phase II study investigating domatinostat plus avelumab in patients with previously treated advanced mismatch repair-proficient oesophagogastric and colorectal adenocarcinoma
المؤلفون: S. Slater, E. Cartwright, C. Saffery, A. Tran, G. Smith, M. Bacason, O. Zhitkov, I. Rana, E. Johnston, I. Sanna, M. Aresu, D. Kohoutova, M. Terlizzo, F. Turkes, E. Smyth, W. Mansoor, C. Fribbens, S. Rao, D. Watkins, N. Starling, I. Chau, D. Cunningham
المصدر: Annals of Oncology. 33:S239
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Oncology, Hematology
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e48043dcd7c8776b4e58f10ff34700bb
https://doi.org/10.1016/j.annonc.2022.04.080
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........e48043dcd7c8776b4e58f10ff34700bb
قاعدة البيانات: OpenAIRE